Identifying a Signaling Pathway with Potential to Treat Melanoma
This study investigates the therapeutic relevance of targeting the Wnt signaling pathways in canine malignant melanoma.
Displaying 50 - 56 of 59 Results
Characterization and Targeting of Cancer Stem Cells in Canine Insulinomas
The aim of this study is to discover drugs that will work against cancer stem cells of an insulin-producing endocrine pancreatic tumor (insulinoma), thereby improving the prognosis of dogs suffering from insulinoma.
Defining the Optimal Dose of Rapamycin
This pilot study will determine the dose and schedule of rapamycin, a promising new adjunct cancer drug.
Developing a Way to Predict Length of Disease-Free Intervals for Dogs with Bone Cancer
This study investigates how cytogenetic changes in canine osteosarcoma affect the duration of disease-free interval when patients are treated with amputation followed by doxorubicin and non-cytotoxic suramin.
Determining How Overexpression of miR-9 Helps Osteosarcoma Spread
This study will provide a molecular framework for understanding the process of miR-9-driven tumor spread in canine osteosarcoma, thereby generating potential new targets for therapy to prevent or treat tumor spread in this devastating disease.
Evaluating a Therapeutic Agent That May Inhibit a Protein Associated with Lymphoma
This study evaluates a new therapeutic agent designed to inhibit the survivin protein in canine lymphoma.
Understanding How Mammary Cancer Develops
This study investigates the role of citrullination in canine mammary cancer and how interfering with this process might lead to more effective anticancer treatments.